9th November 2007
Max Plank Institute celebrate opening of a state-of-the-art Protein Structural Biology Laboratory.
23rd August 2007
Ultimate quality X-ray data from ATLAS – the fastest commercially available CCD detector
11 July 2007
'LIVE' PX SCANNER DEMO AT ACA BOOTH 203
30 March 2007
King’s College London to invest in state-of-the-art equipment for structural biology
18 April 2007
Condolences from Oxford Diffraction to all at Virginia Tech
31 October 2006
Duke of Kent Visits Oxford Diffraction
27 October 2006
Oxford Diffraction announces senior appointments
24 July 2006
Oxford Diffraction announces the launch of the PX Scanner:
the first ever commercial instrument for in-situ X-ray inspection of protein
crystals in multi-well plates.
26 April 2006
Oxford Diffraction announce their innovative Total Care service and support package offering full service and support with a 100% up-time guarantee*.
21 April 2006
Oxford Diffraction wins further acclaim with the award of a 2006 Queen’s award for International Trade
6 March 2006
The University of Western Australia purchases an Xcalibur S CCD diffractometer
for high resolution electron density studies.
26 January 2006
Oxford Diffraction announces a breakthrough in
protein crystallisation with the first ever commercial instrument for combined
optical and in-situ X-ray inspection of crystals in multi-well plates
19 January 2006
Oxford Diffraction release their new CrysAlisPro software
for automated data collection and reduction
25 September 2005
Oxford Diffraction is ranked number 44 in the Sunday Times Microsoft
Tech Track 100 league table of Britain’s 100 fastest growing technology
companies
30 August 2005
One thousand IUCr delegates appear in orange Oxford Diffraction ‘T’ shirts and baseball caps
25 July 2005
The home of CRYSTALS puts Gemini R through its paces at Oxford University, UK
11 July 2005
Oxford Diffraction's ‘Gemini R’ wins R&D100 award as the most significant technology advance for 2005
10 June 2005
Oxford Diffraction launches first combined system for protein and small molecule crystallography
23 May 2005
Oxford Diffraction sells its first protein crystallography system in China
|
![]() |
30 March 2007
King's College London to invest in state-of-the-art equipment for structural biologyThe Randall Division of Cell and Molecular Biophysics at King's College London have confirmed their investment in an Oxford Diffraction PX Scanner and an Xcalibur Nova system.The Randall Division of Cell and Molecular Biophysics at King’s College London has today confirmed a major investment in state-of-the-art equipment for their Structural Biology Laboratory. Infrastructure support for a new X-ray crystallography facility following three new appointments in structural biology, together with a major grant from the Wellcome Trust for robotic crystallisation and imaging equipment, have been used to purchase both the unique PX Scanner plus an Xcalibur Nova system from Oxford Diffraction Limited. The Randall Division’s Structural Biology Laboratory has agreed to become an important reference site for Oxford Diffraction to showcase this combination of instruments. The PX Scanner is the first commercial product to offer combined automated optical inspection with in-situ X-ray diffraction of putative crystals in multi-well plates. An entirely novel product, the PX Scanner was launched in August 2006. The Xcalibur Nova is an X-ray diffractometer for protein crystallography incorporating the 165 mm Onyx CCD detector and the microfocus Nova X-ray source. Xcalibur Nova is the established market leader in this class of instruments. Professor Brian Sutton from King’s College explained the reason for the selection of Oxford Diffraction equipment: “We were extremely impressed with the quality of the trial data that we collected on the Xcalibur Nova system, and are excited about the contribution that the PX Scanner will make to speeding up the process of obtaining crystals suitable for protein structure analysis. My research is aimed at developing inhibitors of IgE antibody interactions for the treatment of allergy and asthma, and this will involve many crystallisation trials and structure determinations of IgE-inhibitor complexes. Rapid screening for crystals that diffract to high resolution will be essential. Since the rate limiting step in most protein crystallographic studies is producing suitably ordered crystals, the PX Scanner, which will enable us to assess crystals without removing them from the crystallisation plate, will accelerate all our research at King’s, such as our work on protein-DNA interactions, antibiotic resistance enzymes, and proteins implicated in neurodegenerative disease”. Dr. Paul Loeffen, CEO of Oxford Diffraction, commented “We are all delighted that the Randall Division has chosen to invest in our equipment. This is a clear demonstration of the power of the combination of our in-situ X-ray screening system, PX Scanner, alongside our X-ray diffractometer, Xcalibur Nova. We look forward to working closely with King’s College over the coming years.” |
![]() |
![]() |





